Study of changes in natalizumab treatment patterns and association with relapse outcomes in patients with multiple sclerosis

Trial Profile

Study of changes in natalizumab treatment patterns and association with relapse outcomes in patients with multiple sclerosis

Completed
Phase of Trial: Phase IV

Latest Information Update: 13 Oct 2014

At a glance

  • Drugs Natalizumab (Primary)
  • Indications Multiple sclerosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 13 Oct 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top